Health TrialsbyHealthPanel

Tenofovir Alafenamide Fumarate

2

Review clinical trials related to Tenofovir Alafenamide Fumarate. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

Tenofovir Exposures in Advanced Kidney Disease Study

Phamacokinetic study to evaluate tenofovir, emtricitabine and tenofovir alafenamide exposures in people with HIV who have chronic kidney disease stage 4 (estimated glomerular filtration rate \[eGFR\] 15-29 mL/min/1.73m2) or stage 3 b (eGFR 30-44 mL/min/1.73m).

Participants needed: 50
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: King's College Hospital NHS TrustUpdated: Sep 10, 2026Locations: 1
Eligibility criteria

Capable of giving informed consent [+10]

Dialysis at screening, Day 1, or in the past 90 days prior to Day 1 [+8]

Read more
Status: Recruiting

Study of Tenofovir Alafenamide in HBV-Infected Pregnant Women

The purpose of this study is to evaluate the pharmacokinetics, efficacy and safety of TAF in HBV-infected pregnant women.

Participants needed: 50
Trial details
Phase: Phase 4Age: 20-40Biological sex: FemaleType: InterventionalSponsor: First People's Hospital of HangzhouUpdated: Sep 8, 2025Locations: 1
Eligibility criteria

Age of 20-40 years; Positive for hepatitis B surface antigen (HBsAg) and hepatit...

Co-infected with hepatitis C or HIV, or other chronic diseases; History of spont...

Read more